HPLC-MS/ESI Determination of Terazosin Hydrochloride,prazosin Hydrochloride and Doxazosin Mesyllate in Human Plasma

MA Ning,LIU Wen-ying,LI Huan-de,CHEN Ben-mei,ZHANG Bi-kui

2007-01-01

Abstract:Objective:To establish an analytical method for simultaneous determination of terazosin hydrochloride, prazosin hydrochloride,doxazosin mesyllate in human plasma by high-performance liquid chromatography/electros- pray-mass spectrometry(HPLC-MS/ESI).Method:Flupentixol dihydrochloride was selected as the internal standard(IS).Samples were extracted using n-hexane/tert- butyl methyl ether(1:1,v/v).The separation was a- chieved on a Hypersil GOLD C_(18)column(100 mm×2.1 mm,5μm)with aqueous solution(20 mmol·μL~(-1)am- monium acetate,0.05 % formic acid,pH 4.2),acetonitrile and methanol as mobile phase with a gradient mode,with a flow rate of 0.2 mL·min~(-1).The quantification of target compounds was using a selective ionization recording[M +H]~+ at m/z 388 for terazosin,m/z 384 for prazosin,m/z 452 for doxazosin and m/z 435 for flupentixol dihydro- chloride.Results:The correlation coefficients of the calibration curves were better than 0.9930(n=7),in the range of 1-100 ng·mL~(-1)for terazosin,prazosin and doxazosin.The average extraction recoveries for all the four analytes were above 83.0%.The methodology recoveries were higher than 97.0%.The intra-day and inter-day RSDs were less than 10.0 %.Conclusion:The method is accurate,sensitive and simple for routine therapeutic drug moni- toring(TDM),as well as for the study of the pharmacokinetics and bioequivalence of the three drugs and has been successfully applied to the bioequivalence study of terazosin hydrochloride tablets.